Document is current

Article History

Received: 24 April 2025

Accepted: 8 July 2025

First Online: 29 July 2025

Declarations

:

: Mark G. Lebwohl is an Editorial Board member of Dermatology and Therapy and was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions; is an employee of Mount Sinai; receives research funds from AbbVie, Arcutis Biotherapeutics, Avotres, Boehringer Ingelheim, Cara Therapeutics, Clexio, Dermavant Sciences, Eli Lilly, Incyte, Inozyme, Janssen, Pfizer, Sanofi-Regeneron, and UCB; and is a consultant for Almirall, AltruBio, Apogee, Arcutis Biotherapeutics, AstraZeneca, Atomwise, Avotres, Boehringer Ingelheim, Bristol-Myers Squibb, Castle Biosciences, Celltrion, CorEvitas, Dermavant Sciences, Dermsquared, Evommune, Facilitation of International Dermatology Education, Forte Biosciences, Galderma, Genentech, Incyte, LEO Pharma, Meiji Seika Pharma, Mindera, Pfizer, Sanofi-Regeneron, Seanergy Dermatology, Strata, Takeda, Trevi Therapeutics, and Verrica. John Y. Koo has been a consultant or speaker for AbbVie, Amgen, Eli Lilly, EPI, Janssen, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, and Sun Pharmaceutical. April W. Armstrong has served as a research investigator for and/or scientific advisor to AbbVie, Almirall, Arcutis Biotherapeutics, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol-Myers Squibb, Dermavant Sciences, Dermira, Eli Lilly, EPI, Incyte, Janssen, LEO Pharma, Mindera, Nimbus, Novartis, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, Sun Pharmaceutical, and UCB. Bruce E. Strober has been an investigator, scientific director, consultant, or member of a speakers bureau or advisory board for AbbVie, Acelyrin, Alamar, Almirall, Alumis, Amgen, Arcutis, Arena, Aristea, Asana, Boehringer Ingelheim, Bristol-Myers Squibb, Capital One, Celltrion, CorEvitas and the CorEvitas Psoriasis Patient Registry, Dermavant, Eli Lilly, Incyte, Inmagene Bio, Janssen, Kangpu Pharmaceuticals, LEO Pharma, Maruho, Meiji Seika Pharma, Monte Carlo, Novartis, Okura, Pfizer, Protagonist, Rapt, Regeneron, Sanofi-Genzyme, SG Cowen, Takeda, UCB Pharma, and Union Therapeutics; holds stock options in Connect Biopharma and Mindera Health; and serves as the editor-in-chief of the Journal of Psoriasis and Psoriatic Arthritis. Soo Han Yoon is an employee of Salix Pharmaceuticals. Nicole N. Rawnsley, Earl L. Goehring Jr, and Abby A. Jacobson are employees of Bausch Health Companies Inc.

: Postmarket monitoring of safety data by drug manufacturers is mandated by the FDA, and ethics committee approval for such monitoring is not required. All data were nonidentifiable and informed consent was not required.